Alexander Ehlgen
About Alexander Ehlgen
Corporate venture investor (Observer, Board of Directors) based in Biberach, Germany. Focus areas include Patient Care, Health Care, Research and Development. Invests at series b, series a stage. Past investments include Aignostics, T3 Pharmaceuticals, Dopavision.
Investment focus
Stages
Sectors
Patient CareHealth CareResearch and DevelopmentHospitalsWellnessCorporate Social Responsibility ManagementWomen FoundedRare DiseasesTransportationHealthcare InnovationChemicalLife ScienceArtificial Intelligence (AI)SoftwareManufacturingBiotechnologyConsumer HealthDrug DevelopmentCosmeticsMarket Research
Portfolio
No portfolio companies recorded yet; Alexander Ehlgen reports 45 investments overall.